top of page

Primary care .png

AEYE For Primary Care

Point of Care Screening

See how it works

Screening for Diabetic Retinopathy Using AI Instead of Referring to a Specialistֿ

AEYE Health’s FDA-cleared AI detects diabetic retinopathy autonomously in just one minute, providing instant results. This enables any clinic staff to screen patients in primary care settings, even while they wait for the physician, effectively closing care gaps and enhancing patient outcomes.

Advantages of AEYE-DS

Vector Art of hand is positioned beneath the eye vector icon symbolizing care and support and representing practical

1-minute Screening

Requires only one image per eye; rarely requires dilation; producing instant diagnosis

Group 6356496.png

Practical to operate

Can be operated with a portable handheld camera and a robotic tabletop camera

Benefits of Point of Care Screening

vector art of reimbursable report

Reimbursable

Dedicated CPT code 92229 for AI diabetic retinopathy screening

Group 6356509_edited.png

Closes Care Gaps

Closes the care diabetic eye gap, improving HEDIS scores and and Star ratings

Vector Art of AEYE Health Care - An image has two vector hands catching the heart representing closes care gaps

Improve Patient Outcomes

Point-of-care screening ensures adherence to screening protocols

See It in Action

AEYE with Topcon

Set up a call to find the best solution for you

Billing and Reimbursement for Diabetic Retinopathy Screening in Primary Care

Visual depiction of the billing and reimbursement process, featuring a central icon representing the exam with three outcomes: reimbursement for primary care providers using CPT 92229, improvement in HEDIS scores, and enhancement of Star-ratings. Additionally, the illustration highlights the addressing of point-of-care screening payment programs.

Reimbursable by Primary Care Providers

CPT code 92229 was created for primary care providers and covers retinal imaging for detection or monitoring of DR, point-of-care automated analysis, and report.

Improves HEDIS scores and Star-ratings

Diabetic Eye Exams performed in primary care can be reported using CPT Category II codes and credited in various HEDIS measurements.

Addresses point-of-care screening payment programs

Screening for diabetic retinopathy addresses MIPS measure 117 and may qualify PCPs for additional payer incentives

Before

Why It Matters

Screening prevents blindness

Accessible and affordable screening for Diabetic Retinopathy is vital to help ensure patients with diabetes receive sight-saving treatment.

Before

After

Visual representation of the existing diabetic retinopathy diagnosis process, where patients are annually referred for a dilated eye exam. Unfortunately, less than 50% of patients adhere to this screening, leading to limited access to the eye exam at the ophthalmologist's office. Those who can access the exam either receive a clear status for 12 months if negative for diabetic retinopathy or initiate treatment if the condition is detected.

Vector Art of Point of Care Screening Solution Process by AEYE Health. The image has Male Doctor photo detecting diabetic reinopathy and screening tool

Autonomous Diagnostic Screening Specialist | AEYE Health

Explore How You Can Implement Sight-Saving Diagnostic Screening

Schedule a Demo

bottom of page